Assessing Thrombotic Risk in Patients with HR+/HER2- Breast Cancer Receiving CDK4/6 Inhibitors: Insights from Real-World Data from the Middle East
评估接受 CDK4/6 抑制剂治疗的 HR+/HER2- 乳腺癌患者的血栓风险:来自中东真实世界数据的启示
期刊:Breast Cancer-Targets and Therapy
影响因子:3.4
doi:10.2147/BCTT.S554024
Alsuhebany, Nada; Alanazi, Ahmed; Alzahrani, Mohammed Y; Alyousef, Saleh; Aldawish, Bandar S; Aljardan, Sultan; Abu Alnasr, Rawan; Althumali, Ibtihal Mohammed; AlDoughaim, Maha; Alfehaid, Lama; Refae, Sadal; Abdelhafiez Jnr, Nafisa Abbas; Bakhribah, Hatoon; Alqahtani, Tariq